Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Vitamin B12 Normal Range, Optimal Levels, and Sex- and Cycle-Related Differences

By
Published Updated Last reviewed
11 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • Common low cutoff / below 200 or 250 pg/mL [1]
  • Borderline zone / 180 to 350 pg/mL; confirm with MMA [2]
  • Suggested MMA cutoff / above 0.271 micromol/L [1]
  • Upper intake limit / none set by NIH ODS [1]
  • Pregnancy / total B12 falls, active holoTC stays stable [4]
  • Persistently high B12 / above 1,000 pg/mL twice warrants evaluation [2]

What is a normal vitamin B12 level?

Most laboratories call serum or plasma B12 below 200 or 250 pg/mL subnormal (200 pg/mL is about 148 pmol/L; 250 pg/mL is about 185 pmol/L) [1]. A 2025 American Family Physician review calls below 180 pg/mL diagnostic, with 180 to 350 pg/mL borderline and requiring MMA [2]. A 2026 expert review notes that no universally accepted definition of deficiency exists [3]. MMA above 0.271 micromol/L suggests deficiency, and MMA also rises with kidney impairment and older age [1]. Measuring at least two of total B12, holotranscobalamin, homocysteine and MMA improves accuracy [5].

Is there an optimal B12 level?

No optimal blood target above the lab ranges is established. The NIH ODS sets no upper intake limit for B12 [1]. A persistently high level above 1,000 pg/mL on two measurements is associated with solid tumors, hematologic malignancy and cardiovascular death; this is an association that warrants evaluation, not evidence that supplements cause disease [2]. VITACOG tested a fixed dose of folic acid, B6 and B12, not a target blood B12 level: 271 older adults with mild cognitive impairment were randomized, 168 completed MRI, and brain atrophy was 0.76% versus 1.08% per year; the 53% lower rate was in participants with homocysteine above 13 micromol/L [6]. In people with high homocysteine and cardiovascular disease, lowering homocysteine with B12 did not reduce heart attack or stroke or change cognitive decline [7].

Are there sex or menstrual-cycle differences?

The adult thresholds above are general, not sex-specific. In a U.S. NHANES analysis of 12,335 adults, females had higher combined B12-status scores than males, but this does not establish a sex-specific cutoff [11]. Pregnancy is the reproductive state with published data: in 27 pregnant Danish women, total serum B12 fell across gestation while holotranscobalamin stayed unchanged; haptocorrin-bound B12 declined and MMA and homocysteine rose [4]. In an Irish case-control study, maternal B12 below 250 ng/L (pg/mL) was associated with the highest neural-tube defect risk, and the authors suggested above 300 ng/L before pregnancy [8]. No cycle-phase cutoff was found in the evidence for this page.

What drugs lower B12?

In the Diabetes Prevention Program Outcomes Study, B12 at or below 203 pg/mL occurred in 4.3% of metformin users versus 2.3% of placebo at 5 years, and 7.4% versus 5.4% at 13 years (not significant); each year of metformin raised deficiency odds (OR 1.13) [9]. Two or more years of PPI use was associated with B12 deficiency (OR 1.65), and H2 blockers with OR 1.25 [10]. A 2018 review found these drugs lower serum B12 but concluded it is unclear whether they cause clinical deficiency [5].

Frequently asked questions

What B12 level is considered low?
Most laboratories use below 200 or 250 pg/mL as subnormal, while a 2025 review calls below 180 pg/mL diagnostic and 180 to 350 pg/mL borderline, requiring an MMA check [1][2].
Is the normal B12 range different for men and women?
No sex-specific cutoff is established. In a U.S. adult analysis females had higher combined B12-status scores than males, but that finding does not define a separate range [11].
Does pregnancy change B12 levels?
Yes. Total serum B12 falls during pregnancy while holotranscobalamin remains stable, and MMA and homocysteine rise; maternal B12 below 250 ng/L has been associated with higher neural-tube defect risk [4][8].
Can high B12 be harmful?
The NIH ODS sets no upper intake limit for B12. A persistently high level above 1,000 pg/mL on two measurements is associated with serious illness and should prompt evaluation, but it is not evidence that B12 supplements are toxic [1][2].
Do metformin or acid blockers lower B12?
Metformin and long-term proton pump inhibitors or H2 blockers lower serum B12, but a 2018 review concluded it remains unclear whether they cause clinical deficiency [9][10][5].

References

  1. NIH Office of Dietary Supplements. Vitamin B12: Health Professional Fact Sheet
  2. Patel H, McGuirk R. Vitamin B12 Deficiency: Common Questions and Answers. Am Fam Physician. 2025;112(3):294-300. Vitamin B12 Deficiency: Common Questions and Answers
  3. Guéant JL, Alpers DH, Allen LH, Andres E, Devlin AM, Green A, et al. Expert Perspectives on Diagnosis and Management of Vitamin B12 Deficiency in Adults. Adv Nutr. 2026;17(10):100726. Expert Perspectives on Diagnosis and Management of Vitamin B12 Deficiency in Adults
  4. Greibe E, Andreasen BH, Lildballe DL, Morkbak AL, Hvas AM, Nexo E. Uptake of cobalamin and markers of cobalamin status: a longitudinal study of healthy pregnant women. Clin Chem Lab Med. 2011;49(11):1877-82. Uptake of cobalamin and markers of cobalamin status: a longitudinal study of healthy pregnant women
  5. Miller JW. Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications. Adv Nutr. 2018;9(4):511S-518S. Proton Pump Inhibitors, H2-Receptor Antagonists, Metformin, and Vitamin B-12 Deficiency: Clinical Implications
  6. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS One. 2010;5(9):e12244. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial
  7. Langan RC, Goodbred AJ. Vitamin B12 Deficiency: Recognition and Management. Am Fam Physician. 2017;96(6):384-389. Vitamin B12 Deficiency: Recognition and Management
  8. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC, et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification. Pediatrics. 2009;123(3):917-23. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification
  9. Aroda VR, Edelstein SL, Goldberg RB, Knowler WC, Marcovina SM, Orchard TJ, et al. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016;101(4):1754-61. Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study
  10. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013;310(22):2435-42. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency
  11. Mineva EM, Sternberg MR, Bailey RL, Storandt RJ, Pfeiffer CM. Fewer US adults had low or transitional vitamin B12 status based on the novel combined indicator of vitamin B12 status compared with individual, conventional markers, NHANES 1999-2004. Am J Clin Nutr. 2021. Fewer US adults had low or transitional vitamin B12 status based on the novel combined indicator of vitamin B12 status compared with individual, conventional markers, NHANES 1999-2004
Evidence overview for Vitamin B12 Normal Range, Optimal Levels, and Sex- and Cycle-Related Differences